- Identify the demographics, prevalence, and outcomes associated with heart failure with preserved ejection fraction.
- Review the current pathophysiological mechanism underlying heart failure with preserved ejection fraction and the relationship to clinical trial outcomes.
- Identify the role of renal insufficiency in heart failure with preserved ejection fraction and describe the current therapeutic interventions.
05/26/2023 - 12:00pm to 1:00pm CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
James Fang, MD